Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies.
Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study.
The British journal of dermatology·2019
Systematic review of the real-world evidence of adalimumab safety in psoriasis registries.
Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Case Report: Polycythemia vera presenting as persistent unexplained low-grade fever.
Frontiers in medicine·2026
AI's top startups are barely publishing their research.
Science (New York, N.Y.)·2026
Lost in Translation.
Journal of the American Academy of Child and Adolescent Psychiatry·2026